The levels of caffeine in your blood could affect the amount of body fat you carry, a factor that in turn could determine your risk of developing type 2 diabetes and cardiovascular diseases.

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

Vitamin D, magnesium, and B12 deficiencies were common among people with type 2 diabetes according to new research.

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

A new review found as many as 45% of Type 2 diabetics are suffering multiple deficiencies in vitamins, minerals and ...

Type 2 diabetes causes a person's blood sugar level to become too high, and can often lead to more serious health conditions ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

Type 2 diabetes (T2D) is a significant global health concern, and early detection is crucial for effective management and prevention of complications. Various risk assessment and screening methods ...

Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney ...